Table 2.
Variables | Patients | HPIP expression
|
P-value | |
---|---|---|---|---|
Low | High | |||
All cases | 119 | |||
Age (years) | 0.921 | |||
<43 | 59 | 27 | 32 | |
≥43 | 60 | 28 | 32 | |
Histological type | 0.236 | |||
SCC | 106 | 51 | 55 | |
Adenocarcinoma | 13 | 4 | 9 | |
Histological grade | <0.001 | |||
G1 | 23 | 14 | 9 | |
G2 | 65 | 37 | 28 | |
G3 | 31 | 4 | 27 | |
FIGO stage | 0.679 | |||
I | 69 | 33 | 36 | |
II | 50 | 22 | 28 | |
Depth of stromal infiltration | 0.015 | |||
<1/2 | 68 | 38 | 30 | |
≥1/2 | 51 | 17 | 34 | |
Tumor size (cm) | 0.218 | |||
<4 | 82 | 41 | 41 | |
≥4 | 37 | 14 | 23 | |
Lymph node metastasis | <0.001 | |||
No | 94 | 52 | 42 | |
Yes | 25 | 3 | 22 | |
LVSI | 0.026 | |||
No | 93 | 48 | 45 | |
Yes | 26 | 7 | 19 | |
Recurrence | 0.029 | |||
No | 104 | 52 | 52 | |
Yes | 15 | 3 | 12 |
Abbreviations: FIGO, the Federation of Gynecology and Obstetrics; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; LVSI, lymphovascular space invasion; SCC, squamous cell carcinoma.